| Nov 20 |
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
|
| Nov 19 |
High Growth Tech Stocks To Explore In November 2024
|
| Nov 18 |
US Penny Stocks To Monitor In November 2024
|
| Nov 14 |
Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
|
| Nov 11 |
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop
|
| Nov 8 |
Ardelyx tumbles as lawsuit against CMS dismissed over Xphozah (update)
|
| Nov 8 |
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
|
| Nov 5 |
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
|
| Nov 2 |
Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023)
|
| Nov 1 |
Q3 2024 Ardelyx Inc Earnings Call
|
